ERBC Advances Drug Safety Science with major publication in Frontiers

ERBC is proud to announce the publication of a new scientific article in the peer-reviewed journal Frontiers, section Cardiovascular Medicine, titled “Cardiovascular safety pharmacology: beyond arrhythmic risk assessment”. The paper, co-authored by our experts in cardiovascular pharmacology, Raafat Fares and Pascal Champéroux, represents a significant contribution to understanding how drugs interact with the cardiovascular system beyond traditional regulatory testing frameworks.